LIVER CIRRHOSIS

This study aims to determine if giving pantoprazole (a common acid-reducing drug) after a preventive variceal treatment helps reduce short-term bleeding risk in people with cirrhosis. It will enroll 208 patients who have undergone this endoscopic procedure and randomly assign the…

This study investigates whether a new antiviral drug called Bulevirtide can reduce dangerous high pressure in the liver (portal hypertension) in people with both hepatitis B and hepatitis D infections who also have liver scarring (cirrhosis). Researchers are measuring pressure ch…

This study is testing whether sending mailed reminders and providing a patient guide can help more people with liver cirrhosis or chronic hepatitis B attend their regular liver cancer screening appointments. Researchers want to see if this support helps catch cancer at an earlier…

This study is testing if a shorter, more affordable MRI scan is better than the standard ultrasound for finding early liver cancer in people with cirrhosis. Researchers will enroll 820 adults with cirrhosis who are already in a screening program. They will compare how well the fa…

This study aims to better understand why some critically ill patients with liver cirrhosis develop a severe, life-threatening fungal lung infection called invasive pulmonary aspergillosis (IPA). Researchers will analyze data and tissue samples from 450 adult patients admitted to …

This study aims to understand how liver disease progresses in people who have experienced a serious health crisis due to permanent liver scarring (cirrhosis). Researchers will follow 24 patients for up to 5 years, collecting information from their regular doctor visits to map the…

This study looks back at the medical records of 624 patients with advanced liver disease who had a procedure called TIPS. The goal is to find common factors that can predict which patients are most likely to develop a serious side effect called hepatic encephalopathy, or 'brain f…